These results demonstrate that THAP1 regulates proteasome function by mediating β5 transcription in vivo, and that the dystonia-associated mutation disrupts this regulation, raising the possilibity of a link between impaired proteasome activity and the pathogenesis of DYT6 dystonia. The gene discussed is THAP1; the disease is Dystonia.